medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2006, Number 07

<< Back Next >>

Ginecol Obstet Mex 2006; 74 (07)

Hyaline membrane disease: mortality and maternal and neonatal risk factors

Pérez MJJ, Blancas JO, Ramírez VJM

Language: Spanish
References: 13
Page: 354-359
PDF size: 255.07 Kb.


ABSTRACT

Objective: To identify maternal and neonatal risk factors associated with hyaline membrane disease and its mortality.
Patients and method: A case-control study with 41 newborns with hyaline membrane disease and 123 controls was made between September 2001 and February 2002 in the Hospital Civil de Guadalajara Dr. Juan I. Menchaca. The diagnosis of hyaline membrane disease was done with clinical and radiographic data. Maternal risk factors were obtained by direct interview with the mother; the newborn data were obtained of the clinical files. The association was measured with the odds ratios (OR) and the confidence interval of 95%.
Results: The frequency of hyaline membrane disease was of 6.8 per 1,000 live births. Mortality rate was of 2.8 per 1,000 live births. There were 17 deaths (41%). The risk factors associated with hyaline membrane were: illness during the first and second trimester of pregnancy, (OR: 3.28 [1.16-9.31]; OR: 8.88 [3.56-22.50], respectively), Apgar score lower than seven at the first minute (OR: 18.57 [4.50–88.67]), and masculine gender (OR: 2.58 [1.15-5.83]).
Conclusions: Frequency and mortality were similar to the reported by other studies made in population samples. The exposure to illnesses during pregnancy and the low Apgar score were associated with the increased frequency of hyaline membrane disease.


REFERENCES

  1. Verma R. Respiratory distress syndrome of the newborn infant. Obstet Gynecol Surv 1995;50:542-55.

  2. Kramer MS. Clinical epidemiology and biostatistic. New York: Springer-Verlag, 1988.

  3. Takenaga-Mesquida R, Sangri-Pinto AG. Enfermedades congénitas y neonatales. En: Cardoso JM, Criales JL, Moncada R, editores. Tórax: pulmón, pleura y mediastino. Philadelphia: Lippincott Williams & Wilkins, 1999;pp:43-63.

  4. Norma Oficial Mexicana NOM-007-SSA2-1993. Atención de la mujer durante el embarazo, parto y puerperio y del recién nacido. Criterios y procedimientos para la prestación del servicio.

  5. Kumar A, Vishnu B. Epidemiology of respiratory distress of newborns. Indian J Pediatr 1996;63:93-98.

  6. Hamvas A, Kwong P, DeBaun M, Schramm W, Cole FS. Hyaline membrane disease is underreported in a linked birth-infant death certificate database. Am J Public Health1998;88:1387-9.

  7. Reed DM, Bakketeig LS, Nugent RP. The epidemiology of respiratory distress syndrome in Norway. Am J Epidemiol 1978;107:299-310.

  8. Hjalmarson O. Epidemiology and classification of acute neonatal respiratory disorders. Acta Paediatr Scand 1981;70:773-83.

  9. Lima-Dávila G, Díaz-del-Castillo E, Espinoza-Luna R, Karchmer S. Epidemiología del síndrome de dificultad respiratoria (SDR). Bol Med Hosp Infant Mex 1982;39:566-9.

  10. Malloy MH, Freeman DH. Respiratory distress syndrome mortality in the United States, 1987 to 1995. J Perinatol 2000;20:414-20.

  11. Gorbea-Robles MC, Chávez-Rojas G, Gómez-Gómez M, García-González ER, et al. Morbimortalidad por enfermedad de membrana hialina en una unidad de cuidados intensivos neonatales. Bol Med Hosp Infant Mex 1988;45:653-8.

  12. Pérez-Molina JJ, Cobián-López BE, Silva-Maciel CA. Factores de riesgo maternos y nacimiento pretérmino en un hospital público del occidente de México. Ginecol Obstet Mex 2004;72:142-9.

  13. Kenny J, Adams JM, Corbert AJS, Rudolph AJ. The role acidosis at birth in the development of hyaline membrane disease. Pediatrics 1976;58:184-91.




2020     |     www.medigraphic.com